Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
Celularity Inc. and Fountain Life announce the availability of cenplacel-L, a placental-derived allogeneic cell therapy, for investigational use by licensed physicians in Florida under recently enacted state legislation. This new regulatory framework allows use of certain cell therapies without FDA approval, enabling physician-directed application …